118 related articles for article (PubMed ID: 34818258)
21. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis.
Lin C; Xiang Y; Sheng J; Liu S; Cui M; Zhang X
J Physiol Biochem; 2020 Aug; 76(3):469-481. PubMed ID: 32621257
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation.
Dastmalchi N; Safaralizadeh R; Hosseinpourfeizi MA; Baradaran B; Khojasteh SMB
Mol Biol Rep; 2021 Feb; 48(2):1345-1357. PubMed ID: 33555529
[TBL] [Abstract][Full Text] [Related]
23. Neferine sensitized Taxol-resistant nasopharygeal carcinoma to Taxol by inhibiting EMT via downregulating miR-130b-5p.
Wang X; Wang K; Xiao J; Song Y; Li H
Biochem Biophys Res Commun; 2020 Oct; 531(4):573-580. PubMed ID: 32811645
[TBL] [Abstract][Full Text] [Related]
24. microRNA-524-5p inhibits proliferation and induces cell cycle arrest of osteosarcoma cells via targeting CDK6.
Chen H; Cheng C; Gao S
Biochem Biophys Res Commun; 2020 Sep; 530(3):566-573. PubMed ID: 32747087
[TBL] [Abstract][Full Text] [Related]
25. MiR-34a-5p/PD-L1 axis regulates cisplatin chemoresistance of ovarian cancer cells.
Zuo Y; Zheng W; Liu J; Tang Q; Wang SS; Yang XS
Neoplasma; 2020 Jan; 67(1):93-101. PubMed ID: 31777260
[TBL] [Abstract][Full Text] [Related]
26. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
[TBL] [Abstract][Full Text] [Related]
27. Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
Kim YW; Kim EY; Jeon D; Liu JL; Kim HS; Choi JW; Ahn WS
Drug Des Devel Ther; 2014; 8():293-314. PubMed ID: 24591819
[TBL] [Abstract][Full Text] [Related]
28. Blocking miR-27a-3p sensitises Taxol resistant osteosarcoma cells through targeting Fbxw7.
Lu B; Feng Z; Fan B; Shi Y
Bull Cancer; 2021 Jun; 108(6):596-604. PubMed ID: 33863546
[TBL] [Abstract][Full Text] [Related]
29. miR-194-5p inhibits SLC40A1 expression to induce cisplatin resistance in ovarian cancer.
Wu J; Zhang L; Wu S; Yi X; Liu Z
Pathol Res Pract; 2020 Jul; 216(7):152979. PubMed ID: 32534701
[TBL] [Abstract][Full Text] [Related]
30. miR-744-5p inhibits cellular proliferation and invasion via targeting ARF1 in epithelial ovarian cancer.
Zhao LG; Wang J; Li J; Li QF
Kaohsiung J Med Sci; 2020 Oct; 36(10):799-807. PubMed ID: 32558345
[TBL] [Abstract][Full Text] [Related]
31. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
Zhang C; Li Y; Zhao W; Liu G; Yang Q
Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression.
Tang X; Jin L; Cao P; Cao K; Huang C; Luo Y; Ma J; Shen S; Tan M; Li X; Zhou M
Oncotarget; 2016 Apr; 7(17):23668-83. PubMed ID: 26993770
[TBL] [Abstract][Full Text] [Related]
33. Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma.
Li X; Pan Q; Wan X; Mao Y; Lu W; Xie X; Cheng X
BMC Cancer; 2015 Jul; 15():509. PubMed ID: 26152689
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells.
Weiner-Gorzel K; Dempsey E; Milewska M; McGoldrick A; Toh V; Walsh A; Lindsay S; Gubbins L; Cannon A; Sharpe D; O'Sullivan J; Murphy M; Madden SF; Kell M; McCann A; Furlong F
Cancer Med; 2015 May; 4(5):745-58. PubMed ID: 25684390
[TBL] [Abstract][Full Text] [Related]
35. [The role of cyclin-dependent kinases in miR-193a5p regulating ovarian cancer cell proliferation and epithelial mesenchymal transformation].
Yang ZJ; DU XL
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Mar; 36(2):176-179. PubMed ID: 32744015
[No Abstract] [Full Text] [Related]
36. miR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition by Targeting CDK6 in Nasal Polyps.
Zhang T; Zhou Y; You B; You Y; Yan Y; Zhang J; Pei Y; Zhang W; Chen J
Am J Rhinol Allergy; 2021 Mar; 35(2):152-163. PubMed ID: 32623901
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA UCA1 promotes the progression of paclitaxel resistance in ovarian cancer by regulating the miR-654-5p/SIK2 axis.
Li ZY; Wang XL; Dang Y; Zhu XZ; Zhang YH; Cai BX; Zheng L
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):591-603. PubMed ID: 32016960
[TBL] [Abstract][Full Text] [Related]
38. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
39. MiR-197 induces Taxol resistance in human ovarian cancer cells by regulating NLK.
Zou D; Wang D; Li R; Tang Y; Yuan L; Long X; Zhou Q
Tumour Biol; 2015 Sep; 36(9):6725-32. PubMed ID: 25833695
[TBL] [Abstract][Full Text] [Related]
40. Circ_SEC61A1 contributes to the progression of multiple myeloma cells via regulating miR-660-5p/CDK6 axis.
Luo Z; Yin Y; Tan X; Liu K; Chao Z; Xia H
Leuk Res; 2022 Feb; 113():106774. PubMed ID: 35030455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
